These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5079698)

  • 1. The laboratory assessment of the efficacy of antihaemophilic therapy.
    Lurie A
    S Afr Med J; 1972 Aug; 46(33):1180-5. PubMed ID: 5079698
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of a single administration of cryoprotein and plasma on factor VIII in hemophilia A].
    Vlcková M; Vorlová Z
    Vnitr Lek; 1980 Nov; 26(11):1101-6. PubMed ID: 6789551
    [No Abstract]   [Full Text] [Related]  

  • 3. [In-vivo control of blood coagulation fractions].
    Richter K; Rex JO; Stinner G; Fünfhausen G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):344-8. PubMed ID: 4195280
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma fractions for the treatment of hemophilia. 1. On the preparation and use of fraction I-O.
    Blombäck M; Blombäck B
    Thromb Diath Haemorrh Suppl; 1969; 35():21-5. PubMed ID: 5317539
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical studies in therapy using coagulation-active plasma concentrates].
    Perlick E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):300-15. PubMed ID: 4195274
    [No Abstract]   [Full Text] [Related]  

  • 6. Human plasma and plasma fractions as sources of factor VIII (antihaemophilic factor).
    Verstraete M; Olislaegers P; Van Itterbeek H; Waumans P; Lust A
    Vox Sang; 1969 Apr; 16(4):382-97. PubMed ID: 5800592
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of methods of freezing and thawing of blood plasma on the activity of procoagulants and antithrombin-III].
    Baryshev BA; Selivanov EA; Kobilianskaia VI; Andozhskaia IV; Kurenkova VV; Papaian LP
    Vestn Khir Im I I Grek; 2000; 159(6):55-6. PubMed ID: 11209233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemophilia A with factor VIII inhibitor].
    Shima M
    Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
    [No Abstract]   [Full Text] [Related]  

  • 9. The laboratory assessment of the efficacy of antihaemophilic therapy.
    Lurie A
    S Afr Med J; 1972 Jun; 46(25):844. PubMed ID: 5076068
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmapheresis of the patient as a method for achieving effective levels of plasma coagulation factors using fresh frozen plasma.
    Perkins HA
    Transfusion; 1966; 6(4):293-301. PubMed ID: 5965695
    [No Abstract]   [Full Text] [Related]  

  • 11. Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia.
    Bennett E; Dormandy KM; Churchill WG; Coward AR; Smith M; Cleghorn TE
    Br Med J; 1967 Apr; 2(5544):88-91. PubMed ID: 6020855
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of hemophilia and its social aspects].
    Digilio G
    Minerva Pediatr; 1967 Nov; 19(44):1963-9. PubMed ID: 5616636
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 14. [The dosage of antihemophilic globulin, or antihemophilic plasma as well as Cohn's fraction I in factor VIII deficiency].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):363-8. PubMed ID: 4195283
    [No Abstract]   [Full Text] [Related]  

  • 15. Designated discussant.
    Djerassi I
    Vox Sang; 1967 Jul; 13(1):126-8. PubMed ID: 6035809
    [No Abstract]   [Full Text] [Related]  

  • 16. [Substitution therapy of hemorrhagic diseases].
    Haupt H
    Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):137-44. PubMed ID: 1225069
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term treatment of hemophilia A with plasma fractions].
    Mey U; Gaerisch F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):357-62. PubMed ID: 4195282
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemophilia: the blood bank's concern?].
    Smit Sibinga CT
    Ned Tijdschr Geneeskd; 1978 Sep; 122(37):1359-62. PubMed ID: 692762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological control of substitution therapy in hemophilia A].
    Lisichkov T
    Vutr Boles; 1972; 11(5):103-7. PubMed ID: 4680013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.